Free Trial
→ Your blueprint for crypto wealth (From Crypto 101 Media) (Ad) Free CL Stock Alerts

Colgate-Palmolive (CL) Financials

Colgate-Palmolive logo
$84.71 0.00 (0.00%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$84.75 +0.04 (+0.05%)
As of 08/8/2025 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Colgate-Palmolive

Annual Income Statements for Colgate-Palmolive

This table shows Colgate-Palmolive's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 2,180 1,384 2,441 2,024 2,400 2,367 2,695 2,166 1,785 2,300 2,889
Consolidated Net Income / (Loss)		 2,339 1,548 2,586 2,174 2,558 2,527 2,860 2,338 1,967 2,455 3,049
Net Income / (Loss) Continuing Operations		 2,339 1,548 2,586 2,174 2,558 2,527 2,860 2,338 1,967 2,455 3,049
Total Pre-Tax Income 		3,533 2,763 3,738 3,487 3,464 3,301 3,647 3,087 2,660 3,392 3,956
Total Operating Income		 3,557 2,789 3,955 3,707 3,694 3,554 3,885 3,332 2,893 3,984 4,268
Total Gross Profit		 10,109 9,399 9,123 9,280 9,231 9,325 10,017 10,375 10,248 11,326 12,161
Total Revenue		 17,277 16,034 15,195 15,454 15,544 15,693 16,471 17,421 17,967 19,457 20,101
Operating Revenue		 17,277 16,034 15,195 15,454 15,544 15,693 16,471 17,421 17,967 19,457 20,101
Total Cost of Revenue		 7,168 6,635 6,072 6,174 6,313 6,368 6,454 7,046 7,719 8,131 7,940
Operating Cost of Revenue		 7,168 6,635 6,072 6,174 6,313 6,368 6,454 7,046 7,719 8,131 7,940
Total Operating Expenses		 6,552 6,610 5,168 5,573 5,537 5,771 6,132 7,043 7,355 7,342 7,893
Selling, General & Admin Expense		 5,982 5,464 5,143 5,400 5,389 5,575 6,019 6,407 6,565 7,151 7,729
Other Operating Expenses / (Income)		 570 1,146 25 173 148 196 113 65 69 191 164
Impairment Charge		 - - - - - 0.00 0.00 571 721 0.00 0.00
Total Other Income / (Expense), net		 -24 -26 -217 -220 -230 -253 -238 -245 -233 -592 -312
Interest Expense		 24 26 99 220 143 145 164 175 167 287 292
Interest & Investment Income		 - - - - - - - - 14 55 67
Other Income / (Expense), net		 - - -118 - -87 -108 -74 -70 -80 -360 -87
Income Tax Expense		 1,194 1,215 1,152 1,313 906 774 787 749 693 937 907
Net Income / (Loss) Attributable to Noncontrolling Interest		 159 164 145 150 158 160 165 172 182 155 160
Basic Earnings per Share		 $2.38 $1.53 $2.74 $2.30 $2.76 $2.76 $3.15 $2.56 $2.13 $2.78 $3.53
Weighted Average Basic Shares Outstanding		 915.10M 902.20M 891.80M 881.80M 870.60M 855.03M 848.56M 840.49M 830.38M 823.15M 811.54M
Diluted Earnings per Share		 $2.36 $1.52 $2.72 $2.28 $2.75 $2.75 $3.14 $2.55 $2.13 $2.77 $3.51
Weighted Average Diluted Shares Outstanding		 915.10M 902.20M 891.80M 881.80M 870.60M 855.03M 848.56M 840.49M 830.38M 823.15M 811.54M
Weighted Average Basic & Diluted Shares Outstanding		 915.10M 902.20M 891.80M 881.80M 870.60M 855.03M 848.56M 840.49M 830.38M 823.15M 811.54M
Cash Dividends to Common per Share		 - - - $1.59 $1.66 $1.71 $1.75 $1.79 $1.86 $1.91 $2.48

Quarterly Income Statements for Colgate-Palmolive

This table shows Colgate-Palmolive's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 5.00 372 502 708 718 683 731 737 738 690 743
Consolidated Net Income / (Loss)		 43 414 534 747 760 729 767 776 777 726 773
Net Income / (Loss) Continuing Operations		 43 414 534 747 760 729 767 776 777 726 773
Total Pre-Tax Income 		132 561 887 956 988 967 1,010 986 993 953 1,007
Total Operating Income		 202 909 974 1,029 1,072 1,047 1,092 1,065 1,064 1,076 1,080
Total Gross Profit		 2,574 2,712 2,787 2,877 2,950 3,039 3,066 3,074 2,982 2,987 3,069
Total Revenue		 4,629 4,770 4,822 4,915 4,950 5,065 5,058 5,033 4,945 4,911 5,110
Operating Revenue		 4,629 4,770 4,822 4,915 4,950 5,065 5,058 5,033 4,945 4,911 5,110
Total Cost of Revenue		 2,055 2,058 2,035 2,038 2,000 2,026 1,992 1,959 1,963 1,924 2,041
Operating Cost of Revenue		 2,055 2,058 2,035 2,038 2,000 2,026 1,992 1,959 1,963 1,924 2,041
Total Operating Expenses		 2,372 1,803 1,813 1,848 1,878 1,992 1,974 2,009 1,918 1,911 1,989
Selling, General & Admin Expense		 1,633 1,758 1,768 1,822 1,803 1,916 1,939 1,979 1,895 1,898 1,963
Other Operating Expenses / (Income)		 18 45 45 26 75 76 35 30 23 13 26
Total Other Income / (Expense), net		 -70 -348 -87 -73 -84 -80 -82 -79 -71 -123 -73
Interest Expense		 69 54 29 - - 73 78 23 189 66 71
Interest & Investment Income		 - - -58 -58 - 15 18 -56 - 15 21
Other Income / (Expense), net		 -15 -294 - -15 - -22 -22 - - -72 -23
Income Tax Expense		 89 147 353 209 228 238 243 210 216 227 234
Net Income / (Loss) Attributable to Noncontrolling Interest		 38 42 32 39 42 46 36 39 39 36 30
Basic Earnings per Share		 - $0.45 $0.61 $0.86 $0.86 $0.83 $0.89 $0.90 $0.91 $0.85 $0.92
Weighted Average Basic Shares Outstanding		 830.38M 829.57M 826.69M 823.37M 823.15M 820.44M 817.09M 817.01M 811.54M 810.42M 808.22M
Diluted Earnings per Share		 $0.01 $0.45 $0.60 $0.86 $0.86 $0.83 $0.89 $0.90 $0.89 $0.85 $0.91
Weighted Average Diluted Shares Outstanding		 830.38M 829.57M 826.69M 823.37M 823.15M 820.44M 817.09M 817.01M 811.54M 810.42M 808.22M
Weighted Average Basic & Diluted Shares Outstanding		 830.38M 829.57M 826.69M 823.37M 823.15M 820.44M 817.09M 817.01M 811.54M 810.42M 808.22M
Cash Dividends to Common per Share		 - $0.95 $0.48 $0.48 - $0.98 $0.50 $0.50 - $0.52 $0.52

Annual Cash Flow Statements for Colgate-Palmolive

This table details how cash moves in and out of Colgate-Palmolive's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 127 -119 345 133 -793 157 5.00 -56 -57 191 130
Net Cash From Operating Activities		 3,298 2,949 3,141 3,054 3,056 3,133 3,719 3,325 2,556 3,745 4,107
Net Cash From Continuing Operating Activities		 3,298 2,949 3,141 3,054 3,056 3,133 3,719 3,325 2,556 3,745 4,107
Net Income / (Loss) Continuing Operations		 2,339 1,548 2,586 2,174 2,558 2,527 2,860 2,338 1,967 2,455 3,049
Consolidated Net Income / (Loss)		 2,339 1,548 2,586 2,174 2,558 2,527 2,860 2,338 1,967 2,455 3,049
Depreciation Expense		 442 449 443 475 511 519 539 556 545 567 605
Non-Cash Adjustments To Reconcile Net Income		 586 1,125 -36 137 115 5.00 59 760 848 366 186
Changes in Operating Assets and Liabilities, net		 -69 -173 148 268 -128 82 261 -329 -804 357 267
Net Cash From Investing Activities		 -859 -685 -499 -471 -1,170 -2,099 -779 -592 -1,601 -742 -534
Net Cash From Continuing Investing Activities		 -859 -685 -499 -471 -1,170 -2,099 -779 -592 -1,601 -742 -534
Purchase of Property, Plant & Equipment		 -757 -691 -593 -553 -436 -335 -410 -567 -696 -705 -561
Acquisitions		 -87 -13 -5.00 0.00 -728 -1,711 -353 0.00 -809 0.00 0.00
Purchase of Investments		 -340 -742 -336 -347 -169 -184 -143 -141 -470 -506 -574
Sale of Property, Plant & Equipment		 0.00 0.00 60 - - - 0.00 0.00 47 0.00 0.00
Sale and/or Maturity of Investments		 283 599 378 391 156 131 124 141 322 502 564
Other Investing Activities, net		 18 -68 -3.00 -6.00 7.00 0.00 3.00 -25 5.00 -33 37
Net Cash From Financing Activities		 -2,170 -2,276 -2,233 -2,450 -2,679 -870 -2,919 -2,774 -952 -2,793 -3,389
Net Cash From Continuing Financing Activities		 -2,170 -2,276 -2,233 -2,450 -2,679 -870 -2,919 -2,774 -952 -2,793 -3,389
Repayment of Debt		 -8,525 -9,181 -7,274 -4,808 -725 -1,426 -564 -898 116 -1,791 -410
Repurchase of Common Equity		 -1,530 -1,551 -1,335 -1,399 -1,238 -1,202 -1,476 -1,320 -1,308 -1,128 -1,739
Payment of Dividends		 -1,446 -1,493 -1,508 -1,529 -1,591 -1,614 -1,753 -1,679 -1,691 -1,749 -1,789
Issuance of Debt		 8,960 9,602 7,438 4,779 546 2,874 0.00 699 1,513 1,495 -89
Other Financing Activities, net		 371 347 446 507 329 498 874 424 418 380 638
Effect of Exchange Rate Changes		 -142 -107 -64 - - -7.00 -16 -15 -60 -19 -54
Cash Interest Paid		 133 131 162 150 194 185 188 194 151 280 302
Cash Income Taxes Paid		 1,009 1,259 932 1,037 847 803 845 890 945 937 933

Quarterly Cash Flow Statements for Colgate-Palmolive

This table details how cash moves in and out of Colgate-Palmolive's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents		 -163 92 -48 132 15 113 31 124 -138 16 103
Net Cash From Operating Activities		 673 735 722 1,152 1,136 681 990 1,167 1,269 600 884
Net Cash From Continuing Operating Activities		 673 735 722 1,152 1,136 681 990 1,167 1,269 600 884
Net Income / (Loss) Continuing Operations		 43 414 534 747 760 729 766 775 779 726 773
Consolidated Net Income / (Loss)		 43 414 534 747 760 729 766 775 779 726 773
Depreciation Expense		 135 128 145 144 150 150 157 150 148 148 151
Non-Cash Adjustments To Reconcile Net Income		 739 274 22 51 19 49 42 71 24 81 26
Changes in Operating Assets and Liabilities, net		 -244 -81 21 210 207 -247 25 171 318 -355 -66
Net Cash From Investing Activities		 -173 -264 -174 -161 -143 -193 -111 -150 -80 -159 -401
Net Cash From Continuing Investing Activities		 -173 -264 -174 -161 -143 -193 -111 -150 -80 -159 -401
Purchase of Property, Plant & Equipment		 -221 -163 -184 -161 -197 -126 -117 -134 -184 -124 -108
Purchase of Investments		 -231 -112 -113 -99 -182 -139 -104 -115 -216 -134 -250
Sale and/or Maturity of Investments		 267 14 132 118 238 78 100 82 304 97 253
Other Investing Activities, net		 4.00 -3.00 -9.00 -19 -2.00 -6.00 10 17 16 2.00 -3.00
Net Cash From Financing Activities		 -666 -375 -580 -846 -992 -361 -845 -904 -1,279 -458 -409
Net Cash From Continuing Financing Activities		 -666 -375 -580 -846 -992 -361 -845 -904 -1,279 -458 -409
Repayment of Debt		 212 -1,422 109 -184 -294 205 -12 -357 -246 192 -225
Repurchase of Common Equity		 -413 -180 -371 -332 -245 -509 -480 -295 -455 -284 -232
Payment of Dividends		 -485 -390 -457 -396 -506 -394 -473 -408 -514 -406 -474
Issuance of Debt		 - 1,495 2.00 - -2.00 1.00 1.00 - -91 0.00 497
Other Financing Activities, net		 20 122 137 66 55 336 119 156 27 40 25
Effect of Exchange Rate Changes		 3.00 -4.00 -16 -13 14 -14 -3.00 11 -48 33 29
Cash Interest Paid		 47 94 35 114 37 123 38 106 35 109 28
Cash Income Taxes Paid		 255 171 279 276 211 150 355 257 171 139 391

Annual Balance Sheets for Colgate-Palmolive

This table presents Colgate-Palmolive's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 13,459 11,935 12,123 12,676 12,161 15,034 15,920 15,040 15,731 16,393 16,046
Total Current Assets		 4,863 4,384 4,338 4,639 3,793 4,179 4,338 4,397 5,113 5,279 5,317
Cash & Equivalents		 1,089 970 1,315 1,535 726 883 888 832 775 966 1,096
Accounts Receivable		 1,552 1,427 1,411 1,480 1,400 1,440 1,264 1,297 1,504 1,586 1,521
Inventories, net		 1,382 1,180 1,171 1,221 1,250 1,400 1,673 1,692 2,074 1,934 1,987
Other Current Assets		 840 807 441 403 417 456 513 576 760 793 713
Plant, Property, & Equipment, net		 4,080 3,796 3,840 4,072 3,881 3,750 3,716 3,730 4,307 4,582 4,422
Plant, Property & Equipment, gross		 - - - - - - - - - - 10,127
Accumulated Depreciation		 - - - - - - - - - - 5,705
Total Noncurrent Assets		 4,516 3,755 3,945 3,965 4,487 7,105 7,866 6,913 6,311 6,532 6,307
Goodwill		 2,307 2,103 2,107 2,218 2,530 3,508 3,824 3,284 3,352 3,410 3,272
Intangible Assets		 1,413 1,346 1,313 1,341 1,637 2,667 2,894 2,462 1,920 1,887 1,756
Noncurrent Deferred & Refundable Income Taxes		 76 67 301 188 152 177 291 193 135 214 195
Other Noncurrent Operating Assets		 720 239 224 218 168 753 857 974 904 1,021 1,084
Total Liabilities & Shareholders' Equity		 13,459 11,935 12,123 12,676 12,161 15,034 15,920 15,040 15,731 16,393 16,046
Total Liabilities		 12,074 11,979 12,106 12,433 11,964 14,476 14,819 14,069 14,925 15,436 15,502
Total Current Liabilities		 3,946 3,534 3,305 3,408 3,341 4,038 4,404 4,051 4,004 4,741 5,759
Short-Term Debt		 504 302 13 11 12 514 267 51 25 330 660
Accounts Payable		 1,231 1,110 1,124 1,212 1,222 1,237 1,393 1,479 1,551 1,698 1,805
Accrued Expenses		 1,917 1,845 1,727 1,831 1,696 1,917 2,341 2,085 2,111 2,377 2,891
Current Deferred & Payable Income Tax Liabilities		 294 277 441 354 411 370 403 436 317 336 403
Total Noncurrent Liabilities		 8,128 8,445 8,801 9,025 8,623 10,438 10,415 10,018 10,921 10,695 9,743
Long-Term Debt		 5,644 6,246 6,520 6,566 6,354 7,333 7,334 7,194 8,741 8,219 7,289
Noncurrent Deferred & Payable Income Tax Liabilities		 261 233 246 204 235 507 426 395 383 361 343
Other Noncurrent Operating Liabilities		 2,223 1,966 2,035 2,255 2,034 2,598 2,655 2,429 1,797 2,115 2,111
Total Equity & Noncontrolling Interests		 1,385 -44 17 243 197 558 1,101 971 806 957 544
Total Preferred & Common Equity		 1,145 -299 -243 -60 -102 117 743 609 401 609 212
Total Common Equity		 1,145 -299 -243 -60 -102 117 743 609 401 609 212
Common Stock		 2,702 2,904 3,157 3,450 3,670 3,954 4,435 4,735 5,012 5,274 5,647
Retained Earnings		 18,832 18,861 19,922 20,531 21,615 22,501 23,699 24,350 24,573 25,289 26,145
Treasury Stock		 -16,862 -18,102 -19,135 -20,181 -21,196 -22,063 -23,045 -24,089 -25,128 -26,017 -27,358
Accumulated Other Comprehensive Income / (Loss)		 -3,507 -3,950 -4,180 -3,855 -4,188 -4,273 -4,345 -4,386 -4,055 -3,937 -4,222
Noncontrolling Interest		 240 255 260 303 299 441 358 362 405 348 332

Quarterly Balance Sheets for Colgate-Palmolive

This table presents Colgate-Palmolive's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Total Assets		 15,731 16,173 16,227 16,043 16,393 16,571 16,480 16,774 16,046 16,647 17,470
Total Current Assets		 5,113 5,466 5,437 5,357 5,279 5,640 5,646 5,806 5,317 5,814 5,996
Cash & Equivalents		 775 867 819 951 966 1,079 1,110 1,234 1,096 1,112 1,215
Accounts Receivable		 1,504 1,590 1,656 1,577 1,586 1,813 1,825 1,712 1,521 1,725 1,773
Inventories, net		 2,074 2,110 2,039 1,931 1,934 1,914 1,922 2,041 1,987 2,125 2,120
Other Current Assets		 760 899 923 898 793 834 789 819 713 852 888
Plant, Property, & Equipment, net		 4,307 4,363 4,431 4,409 4,582 4,497 4,392 4,421 4,422 4,416 4,529
Plant, Property & Equipment, gross		 - 9,815 9,988 9,979 - 10,261 10,167 10,238 - 10,276 10,665
Accumulated Depreciation		 - 5,452 5,557 5,570 - 5,764 5,775 5,817 - 5,860 6,136
Total Noncurrent Assets		 6,311 6,344 6,359 6,277 6,532 6,434 6,442 6,547 6,307 6,417 6,945
Goodwill		 3,352 3,375 3,373 3,327 3,410 3,341 3,320 3,389 3,272 3,334 3,696
Intangible Assets		 1,920 1,918 1,901 1,861 1,887 1,837 1,814 1,834 1,756 1,782 1,904
Noncurrent Deferred & Refundable Income Taxes		 135 179 186 202 214 222 214 219 195 211 218
Other Noncurrent Operating Assets		 904 872 899 887 1,021 1,034 1,094 1,105 1,084 1,090 1,127
Total Liabilities & Shareholders' Equity		 15,731 16,173 16,227 16,043 16,393 16,571 16,480 16,774 16,046 16,647 17,470
Total Liabilities		 14,925 15,748 15,912 15,637 15,436 15,954 15,998 15,938 15,502 15,914 16,418
Total Current Liabilities		 4,004 4,441 4,632 4,602 4,741 5,314 5,350 5,565 5,759 6,861 6,775
Short-Term Debt		 25 37 35 34 330 538 530 527 660 1,698 1,614
Accounts Payable		 1,551 1,609 1,544 1,482 1,698 1,646 1,557 1,625 1,805 1,800 1,790
Accrued Expenses		 2,111 2,498 2,600 2,732 2,377 2,720 2,864 3,066 2,891 2,873 3,050
Current Deferred & Payable Income Tax Liabilities		 317 297 453 354 336 410 399 347 403 490 321
Total Noncurrent Liabilities		 10,921 11,307 11,280 11,035 10,695 10,640 10,648 10,373 9,743 9,053 9,643
Long-Term Debt		 8,741 8,870 8,954 8,690 8,219 8,151 8,146 7,909 7,289 6,571 7,144
Noncurrent Deferred & Payable Income Tax Liabilities		 383 421 363 430 361 392 355 320 343 302 279
Other Noncurrent Operating Liabilities		 1,797 2,016 1,963 1,915 2,115 2,097 2,147 2,144 2,111 2,180 2,220
Total Equity & Noncontrolling Interests		 806 425 315 406 957 617 482 836 544 733 1,052
Total Preferred & Common Equity		 401 -6.00 -64 -9.00 609 230 123 435 212 363 702
Total Common Equity		 401 -6.00 -64 -9.00 609 230 123 435 212 363 702
Common Stock		 5,012 5,069 5,154 5,228 5,274 5,428 5,501 5,608 5,647 5,668 5,712
Retained Earnings		 24,573 24,153 24,258 24,571 25,289 25,164 25,486 25,814 26,145 26,413 26,735
Treasury Stock		 -25,128 -25,245 -25,541 -25,834 -26,017 -26,343 -26,736 -26,913 -27,358 -27,602 -27,821
Accumulated Other Comprehensive Income / (Loss)		 -4,055 -3,983 -3,935 -3,974 -3,937 -4,019 -4,128 -4,074 -4,222 -4,116 -3,924
Noncontrolling Interest		 405 431 379 415 348 387 359 401 332 370 350

Annual Metrics And Ratios for Colgate-Palmolive

This table displays calculated financial ratios and metrics derived from Colgate-Palmolive's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -0.82% -7.19% -5.23% 1.70% 0.58% 0.96% 4.96% 5.77% 3.13% 8.29% 3.31%
EBITDA Growth		 0.10% -19.03% 32.18% -2.29% -1.53% -3.72% 9.71% -12.23% -12.05% 24.81% 14.20%
EBIT Growth		 0.03% -21.59% 37.58% -3.39% -2.70% -4.46% 10.59% -14.41% -13.76% 28.83% 15.37%
NOPAT Growth		 -2.04% -33.65% 75.10% -15.53% 18.03% -0.26% 11.98% -17.17% -15.23% 34.79% 14.08%
Net Income Growth		 -2.95% -33.82% 67.05% -15.93% 17.66% -1.21% 13.18% -18.25% -15.87% 24.81% 24.20%
EPS Growth		 -0.84% -35.59% 78.95% -16.18% 20.61% 0.00% 14.18% -18.79% -16.47% 30.05% 26.71%
Operating Cash Flow Growth		 2.93% -10.58% 6.51% -2.77% 0.07% 2.52% 18.70% -10.59% -23.13% 46.52% 9.67%
Free Cash Flow Firm Growth		 64.59% -21.30% 22.75% -25.50% -3.77% -52.40% 165.97% 7.22% -75.41% 332.39% 41.14%
Invested Capital Growth		 -10.88% -14.12% -5.40% 0.96% 10.44% 28.87% 3.88% -5.50% 19.14% -2.92% -13.38%
Revenue Q/Q Growth		 -0.80% -1.97% -1.16% 1.12% -0.52% 1.32% 1.91% 0.46% 1.27% 1.68% -0.02%
EBITDA Q/Q Growth		 2.72% -25.95% 34.42% -2.47% -3.54% -1.52% -0.68% -14.95% -4.74% 14.32% -1.99%
EBIT Q/Q Growth		 2.98% -28.91% 39.88% -2.96% -4.15% -1.94% -0.94% -17.12% -5.38% 16.38% -2.22%
NOPAT Q/Q Growth		 2.99% -41.05% 72.50% -12.92% 12.76% 1.54% 0.68% -17.50% -5.47% 35.11% 0.25%
Net Income Q/Q Growth		 2.86% -41.25% 68.25% -11.23% 12.79% 1.57% 0.35% -17.73% -6.87% 41.25% 0.56%
EPS Q/Q Growth		 1.72% -44.73% 76.62% -11.97% 13.64% 1.85% 0.32% -18.79% -6.99% 44.27% 0.86%
Operating Cash Flow Q/Q Growth		 2.07% -2.16% -0.54% -2.08% 3.49% 3.57% -0.19% 4.49% -14.49% 14.11% 3.35%
Free Cash Flow Firm Q/Q Growth		 30.34% -21.79% 46.76% -16.03% 1.77% 3.84% -10.66% 13.00% -56.38% 35.47% 29.51%
Invested Capital Q/Q Growth		 -0.03% -6.76% -4.00% -2.38% 2.49% 1.97% 6.75% -4.91% 5.19% 4.41% -7.97%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 58.51% 58.62% 60.04% 60.05% 59.39% 59.42% 60.82% 59.55% 57.04% 58.21% 60.50%
EBITDA Margin		 23.15% 20.19% 28.17% 27.06% 26.49% 25.27% 26.41% 21.92% 18.69% 21.54% 23.81%
Operating Margin		 20.59% 17.39% 26.03% 23.99% 23.76% 22.65% 23.59% 19.13% 16.10% 20.48% 21.23%
EBIT Margin		 20.59% 17.39% 25.25% 23.99% 23.21% 21.96% 23.14% 18.72% 15.66% 18.63% 20.80%
Profit (Net Income) Margin		 13.54% 9.65% 17.02% 14.07% 16.46% 16.10% 17.36% 13.42% 10.95% 12.62% 15.17%
Tax Burden Percent		 66.20% 56.03% 69.18% 62.35% 73.85% 76.55% 78.42% 75.74% 73.95% 72.38% 77.07%
Interest Burden Percent		 99.33% 99.07% 97.42% 94.07% 96.04% 95.79% 95.70% 94.64% 94.56% 93.60% 94.62%
Effective Tax Rate		 33.80% 43.97% 30.82% 37.65% 26.15% 23.45% 21.58% 24.26% 26.05% 27.62% 22.93%
Return on Invested Capital (ROIC)		 34.44% 26.09% 50.81% 43.94% 49.05% 40.73% 39.73% 33.21% 26.44% 33.26% 41.28%
ROIC Less NNEP Spread (ROIC-NNEP)		 34.12% 25.82% 48.03% 41.26% 45.87% 37.66% 37.00% 30.38% 24.05% 27.76% 37.95%
Return on Net Nonoperating Assets (RNNOA)		 84.87% 204.78% -19,206.37% 1,628.37% 1,113.67% 628.67% 305.05% 192.47% 194.94% 245.24% 364.98%
Return on Equity (ROE)		 119.31% 230.87% -19,155.56% 1,672.31% 1,162.73% 669.40% 344.79% 225.68% 221.38% 278.50% 406.26%
Cash Return on Invested Capital (CROIC)		 45.95% 41.29% 56.37% 42.99% 39.13% 15.51% 35.92% 38.87% 8.98% 36.23% 55.62%
Operating Return on Assets (OROA)		 25.92% 21.97% 31.90% 29.90% 29.05% 25.34% 24.62% 21.07% 18.28% 22.56% 25.78%
Return on Assets (ROA)		 17.05% 12.19% 21.50% 17.53% 20.60% 18.58% 18.48% 15.10% 12.78% 15.28% 18.80%
Return on Common Equity (ROCE)		 104.97% 145.65% -384,530.04% -1,948.88% -428.10% 13.30% 178.73% 147.26% 125.83% 159.55% 222.21%
Return on Equity Simple (ROE_SIMPLE)		 204.28% -517.73% -1,064.20% -3,623.33% -2,507.84% 2,159.83% 384.93% 383.91% 490.52% 403.12% 1,438.21%
Net Operating Profit after Tax (NOPAT)		 2,355 1,563 2,736 2,311 2,728 2,721 3,047 2,524 2,139 2,883 3,289
NOPAT Margin		 13.63% 9.75% 18.01% 14.96% 17.55% 17.34% 18.50% 14.49% 11.91% 14.82% 16.36%
Net Nonoperating Expense Percent (NNEP)		 0.33% 0.27% 2.78% 2.67% 3.18% 3.07% 2.73% 2.83% 2.39% 5.50% 3.33%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 22.35% 30.33% 38.73%
Cost of Revenue to Revenue		 41.49% 41.38% 39.96% 39.95% 40.61% 40.58% 39.18% 40.45% 42.96% 41.79% 39.50%
SG&A Expenses to Revenue		 34.62% 34.08% 33.85% 34.94% 34.67% 35.53% 36.54% 36.78% 36.54% 36.75% 38.45%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 37.92% 41.22% 34.01% 36.06% 35.62% 36.77% 37.23% 40.43% 40.94% 37.73% 39.27%
Earnings before Interest and Taxes (EBIT)		 3,557 2,789 3,837 3,707 3,607 3,446 3,811 3,262 2,813 3,624 4,181
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 3,999 3,238 4,280 4,182 4,118 3,965 4,350 3,818 3,358 4,191 4,786
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 44.32 0.00 0.00 0.00 0.00 455.60 91.25 111.74 155.64 104.85 348.38
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.94 3.07 3.22 3.69 2.93 3.40 4.12 3.91 3.47 3.28 3.67
Price to Earnings (P/E)		 23.28 35.52 20.05 28.16 18.95 22.52 25.16 31.42 34.96 27.76 25.56
Dividend Yield		 2.55% 2.74% 2.82% 2.45% 3.17% 2.75% 2.21% 2.22% 2.49% 2.46% 2.19%
Earnings Yield		 4.30% 2.82% 4.99% 3.55% 5.28% 4.44% 3.98% 3.18% 2.86% 3.60% 3.91%
Enterprise Value to Invested Capital (EV/IC)		 8.70 9.94 10.39 11.79 8.81 8.07 9.58 10.13 8.05 8.41 10.96
Enterprise Value to Revenue (EV/Rev)		 3.24 3.43 3.58 4.03 3.31 3.87 4.55 4.30 3.94 3.69 4.03
Enterprise Value to EBITDA (EV/EBITDA)		 14.02 16.98 12.71 14.91 12.49 15.31 17.21 19.60 21.09 17.13 16.93
Enterprise Value to EBIT (EV/EBIT)		 15.76 19.72 14.18 16.82 14.26 17.62 19.65 22.94 25.17 19.81 19.38
Enterprise Value to NOPAT (EV/NOPAT)		 23.80 35.20 19.89 26.97 18.85 22.31 24.57 29.65 33.10 24.90 24.64
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.99 18.65 17.32 20.41 16.83 19.38 20.13 22.50 27.70 19.17 19.73
Enterprise Value to Free Cash Flow (EV/FCFF)		 17.84 22.24 17.93 27.57 23.63 58.62 27.18 25.33 97.49 22.86 18.28
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 4.44 -148.82 384.29 27.07 32.31 14.06 6.90 7.46 10.88 8.93 14.61
Long-Term Debt to Equity		 4.08 -141.95 383.53 27.02 32.25 13.14 6.66 7.41 10.84 8.59 13.40
Financial Leverage		 2.49 7.93 -399.85 39.46 24.28 16.69 8.24 6.33 8.11 8.83 9.62
Leverage Ratio		 7.00 18.94 -891.04 95.38 56.45 36.02 18.66 14.94 17.32 18.22 21.61
Compound Leverage Factor		 6.95 18.76 -868.05 89.72 54.21 34.50 17.86 14.14 16.37 17.05 20.45
Debt to Total Capital		 81.61% 100.68% 99.74% 96.44% 97.00% 93.36% 87.35% 88.18% 91.58% 89.93% 93.59%
Short-Term Debt to Total Capital		 6.69% 4.64% 0.20% 0.16% 0.18% 6.12% 3.07% 0.62% 0.26% 3.47% 7.77%
Long-Term Debt to Total Capital		 74.92% 96.03% 99.54% 96.28% 96.82% 87.25% 84.28% 87.56% 91.32% 86.46% 85.82%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 3.19% 3.92% 3.97% 4.44% 4.56% 5.25% 4.11% 4.41% 4.23% 3.66% 3.91%
Common Equity to Total Capital		 15.20% -4.60% -3.71% -0.88% -1.55% 1.39% 8.54% 7.41% 4.19% 6.41% 2.50%
Debt to EBITDA		 1.54 2.02 1.53 1.57 1.55 1.98 1.75 1.90 2.61 2.04 1.66
Net Debt to EBITDA		 1.27 1.72 1.22 1.21 1.37 1.76 1.54 1.68 2.38 1.81 1.43
Long-Term Debt to EBITDA		 1.41 1.93 1.52 1.57 1.54 1.85 1.69 1.88 2.60 1.96 1.52
Debt to NOPAT		 2.61 4.19 2.39 2.85 2.33 2.88 2.49 2.87 4.10 2.96 2.42
Net Debt to NOPAT		 2.15 3.57 1.91 2.18 2.07 2.56 2.20 2.54 3.74 2.63 2.08
Long-Term Debt to NOPAT		 2.40 4.00 2.38 2.84 2.33 2.70 2.41 2.85 4.09 2.85 2.22
Altman Z-Score		 6.72 6.87 7.13 7.32 7.07 6.12 6.65 7.07 6.51 6.60 7.22
Noncontrolling Interest Sharing Ratio		 12.01% 36.91% -1,907.41% 216.54% 136.82% 98.01% 48.16% 34.75% 43.16% 42.71% 45.30%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.23 1.24 1.31 1.36 1.14 1.03 0.99 1.09 1.28 1.11 0.92
Quick Ratio		 0.67 0.68 0.82 0.88 0.64 0.58 0.49 0.53 0.57 0.54 0.45
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 3,142 2,473 3,035 2,261 2,176 1,036 2,755 2,954 726 3,140 4,432
Operating Cash Flow to CapEx		 435.67% 426.77% 589.31% 552.26% 700.92% 935.22% 907.07% 586.42% 393.84% 531.21% 732.09%
Free Cash Flow to Firm to Interest Expense		 130.91 95.10 30.66 10.28 15.22 7.14 16.80 16.88 4.35 10.94 15.18
Operating Cash Flow to Interest Expense		 137.42 113.42 31.73 13.88 21.37 21.61 22.68 19.00 15.31 13.05 14.07
Operating Cash Flow Less CapEx to Interest Expense		 105.88 86.85 26.34 11.37 18.32 19.30 20.18 15.76 11.42 10.59 12.14
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.26 1.26 1.26 1.25 1.25 1.15 1.06 1.13 1.17 1.21 1.24
Accounts Receivable Turnover		 10.84 10.76 10.71 10.69 10.79 11.05 12.18 13.60 12.83 12.59 12.94
Inventory Turnover		 5.11 5.18 5.17 5.16 5.11 4.81 4.20 4.19 4.10 4.06 4.05
Fixed Asset Turnover		 4.23 4.07 3.98 3.91 3.91 4.11 4.41 4.68 4.47 4.38 4.46
Accounts Payable Turnover		 5.57 5.67 5.44 5.29 5.19 5.18 4.91 4.91 5.10 5.01 4.53
Days Sales Outstanding (DSO)		 33.68 33.91 34.09 34.14 33.81 33.03 29.96 26.83 28.45 28.98 28.21
Days Inventory Outstanding (DIO)		 71.47 70.47 70.66 70.71 71.43 75.95 86.90 87.16 89.04 89.96 90.12
Days Payable Outstanding (DPO)		 65.54 64.39 67.15 69.05 70.36 70.47 74.37 74.39 71.64 72.92 80.52
Cash Conversion Cycle (CCC)		 39.61 39.99 37.60 35.80 34.88 38.50 42.49 39.60 45.85 46.02 37.82
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 6,444 5,534 5,235 5,285 5,837 7,522 7,814 7,384 8,797 8,540 7,397
Invested Capital Turnover		 2.53 2.68 2.82 2.94 2.80 2.35 2.15 2.29 2.22 2.24 2.52
Increase / (Decrease) in Invested Capital		 -787 -910 -299 50 552 1,685 292 -430 1,413 -257 -1,143
Enterprise Value (EV)		 56,048 54,996 54,412 62,334 51,425 60,710 74,869 74,828 70,806 71,784 81,041
Market Capitalization		 50,749 49,163 48,934 56,989 45,486 53,305 67,798 68,053 62,410 63,853 73,856
Book Value per Share		 $1.26 ($0.33) ($0.27) ($0.07) ($0.12) $0.14 $0.87 $0.72 $0.48 $0.74 $0.26
Tangible Book Value per Share		 ($2.83) ($4.18) ($4.12) ($4.12) ($4.92) ($7.07) ($6.97) ($6.09) ($5.83) ($5.69) ($5.89)
Total Capital		 7,533 6,504 6,550 6,820 6,563 8,405 8,702 8,216 9,572 9,506 8,493
Total Debt		 6,148 6,548 6,533 6,577 6,366 7,847 7,601 7,245 8,766 8,549 7,949
Total Long-Term Debt		 5,644 6,246 6,520 6,566 6,354 7,333 7,334 7,194 8,741 8,219 7,289
Net Debt		 5,059 5,578 5,218 5,042 5,640 6,964 6,713 6,413 7,991 7,583 6,853
Capital Expenditures (CapEx)		 757 691 533 553 436 335 410 567 649 705 561
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 332 182 -269 -293 -262 -228 -687 -435 359 -98 -878
Debt-free Net Working Capital (DFNWC)		 1,421 1,152 1,046 1,242 464 655 201 397 1,134 868 218
Net Working Capital (NWC)		 917 850 1,033 1,231 452 141 -66 346 1,109 538 -442
Net Nonoperating Expense (NNE)		 16 15 150 137 170 194 187 186 172 428 240
Net Nonoperating Obligations (NNO)		 5,059 5,578 5,218 5,042 5,640 6,964 6,713 6,413 7,991 7,583 6,853
Total Depreciation and Amortization (D&A)		 442 449 443 475 511 519 539 556 545 567 605
Debt-free, Cash-free Net Working Capital to Revenue		 1.92% 1.14% -1.77% -1.90% -1.69% -1.45% -4.17% -2.50% 2.00% -0.50% -4.37%
Debt-free Net Working Capital to Revenue		 8.22% 7.18% 6.88% 8.04% 2.99% 4.17% 1.22% 2.28% 6.31% 4.46% 1.08%
Net Working Capital to Revenue		 5.31% 5.30% 6.80% 7.97% 2.91% 0.90% -0.40% 1.99% 6.17% 2.77% -2.20%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.38 $1.53 $2.74 $0.00 $2.76 $2.76 $3.15 $2.56 $2.13 $2.78 $3.53
Adjusted Weighted Average Basic Shares Outstanding		 907.08M 892.74M 882.86M 0.00 861.68M 855.03M 848.56M 840.49M 830.38M 823.15M 811.54M
Adjusted Diluted Earnings per Share		 $2.36 $1.52 $2.72 $0.00 $2.75 $2.75 $3.14 $2.55 $2.13 $2.77 $3.51
Adjusted Weighted Average Diluted Shares Outstanding		 907.08M 892.74M 882.86M 0.00 861.68M 855.03M 848.56M 840.49M 830.38M 823.15M 811.54M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 907.08M 892.74M 882.86M 0.00 861.68M 855.03M 848.56M 840.49M 830.38M 823.15M 811.54M
Normalized Net Operating Profit after Tax (NOPAT)		 2,355 1,563 2,736 2,311 2,728 2,721 3,047 2,956 2,672 2,883 3,289
Normalized NOPAT Margin		 13.63% 9.75% 18.01% 14.96% 17.55% 17.34% 18.50% 16.97% 14.87% 14.82% 16.36%
Pre Tax Income Margin		 20.45% 17.23% 24.60% 22.56% 22.29% 21.03% 22.14% 17.72% 14.80% 17.43% 19.68%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 148.21 107.27 38.76 16.85 25.22 23.77 23.24 18.64 16.84 12.63 14.32
NOPAT to Interest Expense		 98.12 60.10 27.64 10.51 19.08 18.76 18.58 14.42 12.81 10.05 11.27
EBIT Less CapEx to Interest Expense		 116.67 80.69 33.37 14.34 22.17 21.46 20.74 15.40 12.96 10.17 12.40
NOPAT Less CapEx to Interest Expense		 66.58 33.52 22.25 7.99 16.03 16.45 16.08 11.18 8.92 7.59 9.34
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 61.82% 96.45% 58.31% 70.33% 62.20% 63.87% 61.29% 71.81% 85.97% 71.24% 58.68%
Augmented Payout Ratio		 127.23% 196.64% 109.94% 134.68% 110.59% 111.44% 112.90% 128.27% 152.47% 117.19% 115.71%

Quarterly Metrics And Ratios for Colgate-Palmolive

This table displays calculated financial ratios and metrics derived from Colgate-Palmolive's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 5.13% 8.43% 7.54% 10.33% 6.93% 6.18% 4.89% 2.40% -0.10% -3.04% 1.03%
EBITDA Growth		 -34.15% -22.60% 10.79% 8.63% 279.50% 58.14% 11.62% 4.92% -0.82% -1.96% -1.55%
EBIT Growth		 -46.11% -25.18% 11.70% 8.80% 473.26% 66.67% 12.12% 5.03% -0.75% -2.05% -1.22%
NOPAT Growth		 -68.93% 2.84% -12.70% 11.05% 1,153.16% 17.66% 41.42% 4.25% 0.96% 3.85% -0.03%
Net Income Growth		 -77.13% -31.34% -16.43% 9.53% 1,667.44% 76.09% 43.63% 3.88% 2.24% -0.41% 0.78%
EPS Growth		 -94.12% -31.82% -16.67% 16.22% 8,500.00% 84.44% 48.33% 4.65% 3.49% 2.41% 2.25%
Operating Cash Flow Growth		 -39.15% 90.41% 36.74% 18.89% 68.80% -7.35% 37.12% 1.30% 11.71% -11.89% -10.71%
Free Cash Flow Firm Growth		 -309.91% -148.35% -124.25% 683.84% 180.29% 405.58% 695.55% -0.90% 82.65% 12.60% -77.73%
Invested Capital Growth		 19.14% 13.50% 10.40% -2.20% -2.92% -2.81% -5.15% -1.72% -13.38% -4.10% 6.80%
Revenue Q/Q Growth		 3.91% 3.05% 1.09% 1.93% 0.71% 2.32% -0.14% -0.49% -1.75% -0.69% 4.05%
EBITDA Q/Q Growth		 -69.79% 130.75% 50.61% 3.49% 5.53% -2.08% 6.30% -2.72% -0.25% -4.95% 4.86%
EBIT Q/Q Growth		 -79.94% 228.88% 58.37% 4.11% 5.72% -2.38% 6.54% -2.47% -0.09% -5.64% 5.28%
NOPAT Q/Q Growth		 -90.91% 919.43% -12.59% 37.12% 2.56% -4.28% 5.06% 1.07% -0.67% -1.54% 1.14%
Net Income Q/Q Growth		 -93.70% 862.79% 28.99% 39.89% 1.74% -4.08% 5.21% 1.17% 0.13% -6.56% 6.47%
EPS Q/Q Growth		 -98.65% 4,400.00% 33.33% 43.33% 0.00% -3.49% 7.23% 1.12% -1.11% -4.49% 7.06%
Operating Cash Flow Q/Q Growth		 -30.55% 9.21% -1.77% 59.56% -1.39% -40.05% 45.37% 17.88% 8.74% -52.72% 47.33%
Free Cash Flow Firm Q/Q Growth		 -1,168.77% 75.05% 36.75% 564.69% 9.47% -5.02% 23.26% -22.67% 101.76% -41.45% -75.62%
Invested Capital Q/Q Growth		 5.19% -3.77% 0.24% -3.61% 4.41% -3.67% -2.18% -0.12% -7.97% 6.66% 8.94%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 55.61% 56.86% 57.80% 58.54% 59.60% 60.00% 60.62% 61.08% 60.30% 60.82% 60.06%
EBITDA Margin		 6.96% 15.58% 23.21% 23.56% 24.69% 23.20% 24.69% 24.14% 24.51% 23.46% 23.64%
Operating Margin		 4.36% 19.06% 20.20% 20.94% 21.66% 20.67% 21.59% 21.16% 21.52% 21.91% 21.14%
EBIT Margin		 4.04% 12.89% 20.20% 20.63% 21.66% 20.24% 21.59% 21.16% 21.52% 20.44% 20.68%
Profit (Net Income) Margin		 0.93% 8.68% 11.07% 15.20% 15.35% 14.39% 15.16% 15.42% 15.71% 14.78% 15.13%
Tax Burden Percent		 32.58% 73.80% 60.20% 78.14% 76.92% 75.39% 75.94% 78.70% 78.25% 76.18% 76.76%
Interest Burden Percent		 70.59% 91.22% 91.07% 94.28% 92.16% 94.34% 92.49% 92.58% 93.33% 94.92% 95.27%
Effective Tax Rate		 67.42% 26.20% 39.80% 21.86% 23.08% 24.61% 24.06% 21.30% 21.75% 23.82% 23.24%
Return on Invested Capital (ROIC)		 3.16% 32.39% 28.09% 37.85% 37.39% 36.88% 39.64% 41.29% 42.47% 41.32% 38.99%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.84% 28.91% 27.40% 37.09% 36.56% 36.11% 38.85% 40.46% 41.70% 40.05% 38.25%
Return on Net Nonoperating Assets (RNNOA)		 23.02% 370.40% 480.21% 383.45% 322.98% 542.34% 767.08% 487.88% 401.06% 438.04% 376.73%
Return on Equity (ROE)		 26.18% 402.79% 508.30% 421.30% 360.38% 579.23% 806.73% 529.18% 443.53% 479.36% 415.72%
Cash Return on Invested Capital (CROIC)		 8.98% 14.43% 15.50% 28.03% 36.23% 38.87% 44.57% 42.21% 55.62% 45.38% 33.32%
Operating Return on Assets (OROA)		 4.72% 14.83% 23.62% 24.42% 26.23% 24.41% 26.39% 25.93% 26.67% 24.55% 24.37%
Return on Assets (ROA)		 1.08% 9.98% 12.95% 17.99% 18.60% 17.36% 18.53% 18.89% 19.47% 17.75% 17.82%
Return on Common Equity (ROCE)		 14.88% 110.04% 60.55% 177.01% 206.45% 124.52% 59.72% 181.51% 242.60% 210.56% 223.58%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% -2,614.06% 0.00% 0.00% 1,204.35% 2,441.46% 697.01% 0.00% 839.12% 0.00%
Net Operating Profit after Tax (NOPAT)		 66 671 586 804 825 789 829 838 833 820 829
NOPAT Margin		 1.42% 14.06% 12.16% 16.36% 16.66% 15.58% 16.40% 16.65% 16.84% 16.69% 16.22%
Net Nonoperating Expense Percent (NNEP)		 0.32% 3.48% 0.68% 0.76% 0.83% 0.77% 0.79% 0.83% 0.77% 1.27% 0.74%
Return On Investment Capital (ROIC_SIMPLE)		 0.69% - - - 8.67% - - - 9.80% 9.11% 8.45%
Cost of Revenue to Revenue		 44.39% 43.14% 42.20% 41.46% 40.40% 40.00% 39.38% 38.92% 39.70% 39.18% 39.94%
SG&A Expenses to Revenue		 35.28% 36.86% 36.67% 37.07% 36.42% 37.83% 38.34% 39.32% 38.32% 38.65% 38.41%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 51.24% 37.80% 37.60% 37.60% 37.94% 39.33% 39.03% 39.92% 38.79% 38.91% 38.92%
Earnings before Interest and Taxes (EBIT)		 187 615 974 1,014 1,072 1,025 1,092 1,065 1,064 1,004 1,057
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 322 743 1,119 1,158 1,222 1,175 1,249 1,215 1,212 1,152 1,208
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 155.64 0.00 0.00 0.00 104.85 320.51 644.00 194.02 348.38 208.31 104.31
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 3.47 3.30 3.32 2.99 3.28 3.73 3.96 4.20 3.67 3.79 3.66
Price to Earnings (P/E)		 34.96 37.86 41.44 36.01 27.76 28.23 27.89 29.42 25.56 26.11 25.18
Dividend Yield		 2.49% 2.58% 2.53% 2.75% 2.46% 2.14% 2.01% 1.90% 2.19% 2.15% 2.24%
Earnings Yield		 2.86% 2.64% 2.41% 2.78% 3.60% 3.54% 3.59% 3.40% 3.91% 3.83% 3.97%
Enterprise Value to Invested Capital (EV/IC)		 8.05 8.15 8.32 7.99 8.41 9.93 10.83 11.45 10.96 10.54 9.44
Enterprise Value to Revenue (EV/Rev)		 3.94 3.76 3.78 3.41 3.69 4.14 4.36 4.58 4.03 4.17 4.06
Enterprise Value to EBITDA (EV/EBITDA)		 21.09 21.96 19.75 17.82 17.13 17.68 18.00 18.84 16.93 17.46 17.10
Enterprise Value to EBIT (EV/EBIT)		 25.17 26.47 23.28 20.98 19.81 20.26 20.55 21.52 19.38 19.99 19.56
Enterprise Value to NOPAT (EV/NOPAT)		 33.10 31.99 34.40 30.61 24.90 27.18 26.83 28.04 24.64 25.04 24.43
Enterprise Value to Operating Cash Flow (EV/OCF)		 27.70 23.74 22.78 19.91 19.17 22.14 22.01 23.15 19.73 20.65 20.69
Enterprise Value to Free Cash Flow (EV/FCFF)		 97.49 60.02 56.34 28.18 22.86 25.19 23.65 26.88 18.28 22.73 29.25
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 10.88 20.96 28.54 21.49 8.93 14.08 18.00 10.09 14.61 11.28 8.33
Long-Term Debt to Equity		 10.84 20.87 28.43 21.40 8.59 13.21 16.90 9.46 13.40 8.96 6.79
Financial Leverage		 8.11 12.81 17.52 10.34 8.83 15.02 19.74 12.06 9.62 10.94 9.85
Leverage Ratio		 17.32 27.66 36.58 22.16 18.22 31.42 41.04 26.42 21.61 24.61 22.13
Compound Leverage Factor		 12.22 25.23 33.32 20.89 16.79 29.65 37.96 24.46 20.17 23.36 21.08
Debt to Total Capital		 91.58% 95.45% 96.61% 95.55% 89.93% 93.37% 94.74% 90.98% 93.59% 91.86% 89.28%
Short-Term Debt to Total Capital		 0.26% 0.40% 0.38% 0.37% 3.47% 5.78% 5.79% 5.68% 7.77% 18.86% 16.45%
Long-Term Debt to Total Capital		 91.32% 95.05% 96.24% 95.18% 86.46% 87.59% 88.95% 85.30% 85.82% 72.99% 72.82%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 4.23% 4.62% 4.07% 4.55% 3.66% 4.16% 3.92% 4.32% 3.91% 4.11% 3.57%
Common Equity to Total Capital		 4.19% -0.06% -0.69% -0.10% 6.41% 2.47% 1.34% 4.69% 2.50% 4.03% 7.16%
Debt to EBITDA		 2.61 2.84 2.52 2.38 2.04 1.88 1.79 1.73 1.66 1.74 1.85
Net Debt to EBITDA		 2.38 2.56 2.29 2.12 1.81 1.65 1.56 1.47 1.43 1.50 1.59
Long-Term Debt to EBITDA		 2.60 2.82 2.51 2.37 1.96 1.76 1.68 1.62 1.52 1.38 1.51
Debt to NOPAT		 4.10 4.13 4.38 4.09 2.96 2.89 2.67 2.57 2.42 2.49 2.64
Net Debt to NOPAT		 3.74 3.73 3.98 3.64 2.63 2.53 2.33 2.19 2.08 2.16 2.27
Long-Term Debt to NOPAT		 4.09 4.11 4.36 4.07 2.85 2.71 2.51 2.41 2.22 1.98 2.15
Altman Z-Score		 5.96 5.73 5.84 5.79 6.08 6.32 6.59 6.76 6.58 6.39 6.11
Noncontrolling Interest Sharing Ratio		 43.16% 72.68% 88.09% 57.98% 42.71% 78.50% 92.60% 65.70% 45.30% 56.07% 46.22%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.28 1.23 1.17 1.16 1.11 1.06 1.06 1.04 0.92 0.85 0.89
Quick Ratio		 0.57 0.55 0.53 0.55 0.54 0.54 0.55 0.53 0.45 0.41 0.44
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -1,347 -336 -213 988 1,082 1,027 1,266 979 1,976 1,157 282
Operating Cash Flow to CapEx		 304.52% 450.92% 392.39% 715.53% 576.65% 540.48% 846.15% 870.90% 689.67% 483.87% 818.52%
Free Cash Flow to Firm to Interest Expense		 -19.52 -6.23 -7.33 0.00 0.00 17.71 57.56 42.57 10.45 17.53 3.97
Operating Cash Flow to Interest Expense		 9.75 13.61 24.90 0.00 0.00 11.74 45.00 50.74 6.71 9.09 12.45
Operating Cash Flow Less CapEx to Interest Expense		 6.55 10.59 18.55 0.00 0.00 9.57 39.68 44.91 5.74 7.21 10.93
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.17 1.15 1.17 1.18 1.21 1.21 1.22 1.23 1.24 1.20 1.18
Accounts Receivable Turnover		 12.83 11.75 11.87 12.75 12.59 11.61 11.48 12.23 12.94 11.28 11.12
Inventory Turnover		 4.10 3.94 3.98 4.09 4.06 4.03 4.07 4.02 4.05 3.88 3.90
Fixed Asset Turnover		 4.47 4.52 4.56 4.49 4.38 4.46 4.53 4.55 4.46 4.48 4.48
Accounts Payable Turnover		 5.10 4.98 5.28 5.42 5.01 4.98 5.20 5.13 4.53 4.55 4.71
Days Sales Outstanding (DSO)		 28.45 31.07 30.74 28.63 28.98 31.44 31.78 29.85 28.21 32.37 32.83
Days Inventory Outstanding (DIO)		 89.04 92.60 91.78 89.27 89.96 90.68 89.73 90.87 90.12 94.04 93.53
Days Payable Outstanding (DPO)		 71.64 73.25 69.13 67.40 72.92 73.35 70.25 71.08 80.52 80.24 77.45
Cash Conversion Cycle (CCC)		 45.85 50.42 53.40 50.50 46.02 48.77 51.27 49.64 37.82 46.18 48.92
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 8,797 8,465 8,485 8,179 8,540 8,227 8,048 8,038 7,397 7,890 8,595
Invested Capital Turnover		 2.22 2.30 2.31 2.31 2.24 2.37 2.42 2.48 2.52 2.48 2.40
Increase / (Decrease) in Invested Capital		 1,413 1,007 799 -184 -257 -238 -437 -141 -1,143 -337 547
Enterprise Value (EV)		 70,806 68,970 70,588 65,328 71,784 81,714 87,137 92,003 81,041 83,145 81,121
Market Capitalization		 62,410 60,499 62,039 57,140 63,853 73,717 79,212 84,400 73,856 75,618 73,228
Book Value per Share		 $0.48 ($0.01) ($0.08) ($0.01) $0.74 $0.28 $0.15 $0.53 $0.26 $0.45 $0.87
Tangible Book Value per Share		 ($5.83) ($6.38) ($6.43) ($6.29) ($5.69) ($6.03) ($6.11) ($5.86) ($5.89) ($5.86) ($6.04)
Total Capital		 9,572 9,332 9,304 9,130 9,506 9,306 9,158 9,272 8,493 9,002 9,810
Total Debt		 8,766 8,907 8,989 8,724 8,549 8,689 8,676 8,436 7,949 8,269 8,758
Total Long-Term Debt		 8,741 8,870 8,954 8,690 8,219 8,151 8,146 7,909 7,289 6,571 7,144
Net Debt		 7,991 8,040 8,170 7,773 7,583 7,610 7,566 7,202 6,853 7,157 7,543
Capital Expenditures (CapEx)		 221 163 184 161 197 126 117 134 184 124 108
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 359 195 21 -162 -98 -215 -284 -466 -878 -461 -380
Debt-free Net Working Capital (DFNWC)		 1,134 1,062 840 789 868 864 826 768 218 651 835
Net Working Capital (NWC)		 1,109 1,025 805 755 538 326 296 241 -442 -1,047 -779
Net Nonoperating Expense (NNE)		 23 257 52 57 65 60 62 62 56 94 56
Net Nonoperating Obligations (NNO)		 7,991 8,040 8,170 7,773 7,583 7,610 7,566 7,202 6,853 7,157 7,543
Total Depreciation and Amortization (D&A)		 135 128 145 144 150 150 157 150 148 148 151
Debt-free, Cash-free Net Working Capital to Revenue		 2.00% 1.06% 0.11% -0.85% -0.50% -1.09% -1.42% -2.32% -4.37% -2.31% -1.90%
Debt-free Net Working Capital to Revenue		 6.31% 5.79% 4.50% 4.12% 4.46% 4.37% 4.13% 3.82% 1.08% 3.26% 4.18%
Net Working Capital to Revenue		 6.17% 5.59% 4.31% 3.95% 2.77% 1.65% 1.48% 1.20% -2.20% -5.25% -3.90%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.45 $0.61 $0.86 $0.86 $0.83 $0.89 $0.90 $0.91 $0.85 $0.92
Adjusted Weighted Average Basic Shares Outstanding		 830.38M 829.57M 826.69M 823.37M 823.15M 820.44M 817.09M 817.01M 811.54M 810.42M 808.22M
Adjusted Diluted Earnings per Share		 $0.01 $0.45 $0.60 $0.86 $0.86 $0.83 $0.89 $0.90 $0.89 $0.85 $0.91
Adjusted Weighted Average Diluted Shares Outstanding		 830.38M 829.57M 826.69M 823.37M 823.15M 820.44M 817.09M 817.01M 811.54M 810.42M 808.22M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 830.38M 829.57M 826.69M 823.37M 823.15M 820.44M 817.09M 817.01M 811.54M 810.42M 808.22M
Normalized Net Operating Profit after Tax (NOPAT)		 141 671 586 804 825 789 829 838 833 820 829
Normalized NOPAT Margin		 3.05% 14.06% 12.16% 16.36% 16.66% 15.58% 16.40% 16.65% 16.84% 16.69% 16.22%
Pre Tax Income Margin		 2.85% 11.76% 18.39% 19.45% 19.96% 19.09% 19.97% 19.59% 20.08% 19.41% 19.71%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 2.71 11.39 33.59 0.00 0.00 17.67 49.64 46.30 5.63 15.21 14.89
NOPAT to Interest Expense		 0.95 12.42 20.22 0.00 0.00 13.61 37.69 36.44 4.41 12.42 11.68
EBIT Less CapEx to Interest Expense		 -0.49 8.37 27.24 0.00 0.00 15.50 44.32 40.48 4.66 13.33 13.37
NOPAT Less CapEx to Interest Expense		 -2.25 9.40 13.88 0.00 0.00 11.44 32.38 30.62 3.43 10.54 10.16
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 85.97% 95.78% 103.05% 99.42% 71.24% 63.29% 58.91% 58.74% 58.68% 59.13% 59.04%
Augmented Payout Ratio		 152.47% 156.41% 166.89% 173.99% 117.19% 115.88% 111.06% 109.17% 115.71% 108.83% 100.52%

Key Financial Trends

Colgate-Palmolive (NYSE: CL) has demonstrated steady financial performance over the last several years, supported by stable revenue growth, solid profitability, and prudent cash management. Here are some of the key takeaways from the recent financial statements covering Q2 2025 through several prior quarters:

  • Consistent Revenue Growth: Operating revenue increased from approximately $4.77 billion in Q1 2023 to $5.11 billion in Q2 2025, showing a steady upward trend in top-line sales.
  • Sustained Profitability: Net income attributable to common shareholders grew from $372 million in Q1 2023 to $743 million in Q2 2025, reflecting improved profitability over time.
  • Growing Earnings Per Share (EPS): Basic EPS increased from $0.45 in Q1 2023 to $0.92 in Q2 2025, demonstrating effective earnings growth relative to shares outstanding.
  • Robust Operating Cash Flows: Net cash provided by operating activities was $884 million in Q2 2025, up from $735 million in Q1 2023, indicating strong cash generation from core business operations.
  • Controlled Capital Expenditures: Capital expenditures (property, plant & equipment) remained moderate at around $108 million in Q2 2025, supporting ongoing business without excessive cash outflows.
  • Active Share Repurchases: The company repurchased common equity consistently each quarter, exemplified by $232 million repurchased in Q2 2025, supporting shareholder value and lowering shares outstanding.
  • Stable Dividend Policy: Dividends per share steadily increased from $0.48 in Q2 2023 to $0.52 in Q2 2025, reflecting commitment to returning cash to shareholders.
  • Moderate Debt Management: The balance sheet shows long-term debt around $7.1 billion in Q2 2025, with ongoing issuances and repayments that the company manages actively to maintain leverage balance.
  • Working Capital Fluctuations: Changes in working capital occasionally pressured cash flows, for example, a negative $66 million change in operating assets and liabilities in Q2 2025.
  • Elevated Operating Expenses: Selling, General & Admin expenses were high relative to gross profit, roughly $1.96 billion compared to $3.07 billion gross profit in Q2 2025, which could pressure margins if not managed effectively.

Summary: Overall, Colgate-Palmolive exhibits a positive financial trajectory with growing revenues and profits, solid cash flow generation, and shareholder-friendly actions such as dividends and buybacks. Some areas to monitor include expense control to sustain margins and working capital management. The company’s balance sheet remains strong with manageable debt levels and healthy liquidity evidenced by over $1.2 billion in cash and equivalents as of Q2 2025.

08/09/25 03:05 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Colgate-Palmolive's Financials

When does Colgate-Palmolive's financial year end?

According to the most recent income statement we have on file, Colgate-Palmolive's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Colgate-Palmolive's net income changed over the last 10 years?

Colgate-Palmolive's net income appears to be on an upward trend, with a most recent value of $3.05 billion in 2024, rising from $2.34 billion in 2014. The previous period was $2.46 billion in 2023. See where experts think Colgate-Palmolive is headed by visiting Colgate-Palmolive's forecast page.

What is Colgate-Palmolive's operating income?
Colgate-Palmolive's total operating income in 2024 was $4.27 billion, based on the following breakdown:
  • Total Gross Profit: $12.16 billion
  • Total Operating Expenses: $7.89 billion
How has Colgate-Palmolive's revenue changed over the last 10 years?

Over the last 10 years, Colgate-Palmolive's total revenue changed from $17.28 billion in 2014 to $20.10 billion in 2024, a change of 16.3%.

How much debt does Colgate-Palmolive have?

Colgate-Palmolive's total liabilities were at $15.50 billion at the end of 2024, a 0.4% increase from 2023, and a 28.4% increase since 2014.

How much cash does Colgate-Palmolive have?

In the past 10 years, Colgate-Palmolive's cash and equivalents has ranged from $726 million in 2018 to $1.54 billion in 2017, and is currently $1.10 billion as of their latest financial filing in 2024.

How has Colgate-Palmolive's book value per share changed over the last 10 years?

Over the last 10 years, Colgate-Palmolive's book value per share changed from 1.26 in 2014 to 0.26 in 2024, a change of -79.3%.


Related Companies

This page (NYSE:CL) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners
Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Crypto 101 Media | Sponsored
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsored
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored